Qianhong Pharmaceutical's 2026 Interim Net Profit at 153 Million Yuan, Down 40.78% Year-on-Year

Earnings
โดย Jiemian·Read original
Summary · why it matters

Qianhong Pharmaceutical released its 2026 interim report, with net profit attributable to the parent company at 153 million yuan, a decline of 40.78% from the same period last year. Total operating revenue was 758 million yuan, down 12.00% year-on-year. Net cash inflow from operating activities was 178 million yuan. The latest gross margin was 53.26%, a decrease of 3.06 percentage points from the same period last year; ROE was 5.58%, a decrease of 4.25 percentage points.

Impact on stocks 1

Others▼ · 1 stocks
© 2026 MarketDXNews